Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients.
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment.
Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage.
Regulation of B cell function by the immunosuppressive agent leflunomide.
A randomized controlled phase II trial of riluzole in early multiple sclerosis.
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.
Benzothiazole and stilbene derivatives as promising PET myelin radiotracers for multiple sclerosis.
Nanoparticle transport across the blood brain barrier.
Ampyra (dalfampridine)
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
American Neurological Association Annual Meeting
Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.
Receptos to deliver scientific presentation at Digestive Disease Week 2012 about the therapeutic role of RPC1063 in inflammatory bowel disease
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis.
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease.
Combined structural and functional patterns discriminating upper limb motor disability in multiple sclerosis using multivariate approaches.
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Treatment satisfaction in multiple sclerosis.
U.S. Patent Office Declares an Interference Between Forward Pharma and Biogen Regarding the Treatment of Multiple Sclerosis With 480 mg Daily Dose of DMF, the Active Ingredient in Tecfidera(R)
UCSF Seminar: "Neuron-glia interactions regulate CNS node of Ranvier assembly."
Effects of Gadolinium Contrast Agent Administration on Automatic Brain Tissue Classification of Patients with Multiple Sclerosis.
Our Products (page shows "Copaxone" as a trade name for glatiramer acetate)
Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment.
Site-Specific PEGylation Enhances the Pharmacokinetic Properties and Antitumor Activity of Interferon Beta-1b.

Pages